Senseonics Holdings Inc. has teamed up with Roche Diabetes Care Inc. and Typezero Technologies Inc. to develop a long-term automated insulin delivery system. The collaboration is part of the National Institutes of Health-funded International Diabetes Closed Loop (IDCL) multicenter trial, which was designed to test multiple automated insulin delivery systems.